• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Eleanor Perfetto, PhD, MS, Discusses How HEOR Departments Use Comparative Effectiveness Research

Video

Comparative effectiveness research (CER) collaborative tools can benefit pharmaceutical companies in a variety of ways.

Comparative effectiveness research (CER) collaborative tools can benefit pharmaceutical companies in a variety of ways. Eleanor Perfetto, PhD, MS, professor, pharmaceutical health services research, School of Pharmacy, University of Maryland, for instance, suggests that CER can be utilized in internal training programs as well as in making research studies translatable to managed care organizations and their leaders.

“For the most part, the responsibilities within the company are to get a drug approved, and that relies heavily on a randomized control trial design. Now that we have decision-makers who are out there looking at aspects beyond what the FDA would be looking for when a drug is being approved, they’re looking for some of the endpoints the FDA would consider secondary,” says Dr Perfetto.

She adds that the role of HEOR groups within pharmaceutical organizations will continue to grow and evolve.

Related Videos
Will Shapiro
Pat Van Burkleo
Jeff Stark, MD, vice president, head of medical immunology, UCB
Robert Groves, MD
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Dr Padma Sripada, Columbia Internal Medicine
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr amy paller
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.